Board of Directors

 

Melanie Willows MD, CCFP, CSAM (Certificant), ABAM (Diplomate)
President - Term: 2018-2020

Melanie Willows MD, CCFP, CSAM (Certificant), ABAM (Diplomate)

Melanie Willows MD, CCFP, CSAM (Certificant), ABAM (Diplomate)

Dr. Willows completed her family medicine residency at Queen’s University following completion of medical school at the University of Ottawa. Dr. Willows received certification by examination from the American Society of Addiction Medicine in 2004, is a diplomat of the American Board of Addiction Medicine and has also been a certificant with the Canadian Society of Addiction Medicine since 2005.

Dr. Willows is also an Assistant Professor at the University of Ottawa in the Department of Family Medicine with a cross-appointment in the Department of Psychiatry.  She is an active teacher at the University of Ottawa providing both didactic lectures to medical students and regular clinical supervision to medical students, psychiatry residents and family medicine residents.

Dr. Willows provides clinical and academic leadership in addictions and co-occurring disorders within her department, hospital, and community.  She has been working at The Royal Ottawa Mental Health Centre since 2001 and is the Clinical Director of the Substance Use and Concurrent Disorders Program.

Dr. Willows provides assessment and treatment for the full spectrum of addictive disorders and concurrent mental health disorders. She also provides care to physicians through the Ontario Medical Association Physician Health Program.  Dr. Willows leads several initiatives to build capacity amongst primary care providers and other health professionals to identify, assess, and treat substance use and co-occurring disorders within their practice.

Dr. Willows is committed to collaborating with clinicians and researchers to develop new services that address gaps in concurrent disorders treatment, with a current focus on women and transitional aged youth. In 2013 the Ontario Ministry of Health Innovation Fund awarded the “Best Innovation in Mental Health Care Delivery” to Dr. Willows and her colleague for their Regional Opioid Intervention Service.

Dr. Willows has been a member of CSAM since 2004 and is currently on the following CSAM committee(s): Conference and Education.

Dr. Willows has been a CSAM Board Representative for Ontario from 2012 to present.

2019 Conflict of Interest

Jennifer Brasch BSc, MD, FRCPC
President Elect - Term: 2018-2020, Ontario Regional Director and Conference Co-Chair - 1st Term: 2017-2021

Jennifer Brasch BSc, MD, FRCPC

Dr. Jennifer Brasch BSc, MD, FRCPC

Dr. Jennifer Brasch completed her medical training at Queen’s University in 1991 and a Psychiatry residency at McMaster University in 1996.  She is an Associate Professor in the Department of Psychiatry and Behavioural Neurosciences at McMaster University and a member of the Boris Centre for Addictions.

Dr. Brasch is a psychiatrist with the Concurrent Disorders Program of St. Joseph’s Healthcare in Hamilton, and a methadone prescriber at the Hamilton Clinic. She frequently gives presentations on addictions and concurrent disorders, including presenting a week-long course on concurrent disorders for the McMaster Muskoka Seminars in 2015 & 16, and was featured in a video by the OMA for her work in concurrent disorders:  https://www.youtube.com/watch?v=yWWHaXxaKhA.

Dr. Brasch was the Medical Director of the Psychiatric Emergency Service at St. Joseph’s Healthcare Hamilton from 2000 – 2014. She is currently the President of the Hamilton Academy of Medicine and is the lead for The Reasons to Go On Living Project http://www.thereasons.ca/.

Dr. Brasch has been a CSAM member since 2013 and is a newly elected CSAM Board Representative for the Province of Ontario (2016).

2019 Conflict of Interest

Paul Sobey MD, CCFP, CSAM (Certificant), ABAM (Diplomate)
Past President - Term: 2018-2020

Paul Sobey MD, CCFP, CSAM (Certificant), ABAM (Diplomate)

Paul Sobey MD, CCFP, CSAM (Certificant), ABAM (Diplomate)

Dr. Sobey completed medical school at the University of Alberta in 1986, and a fellowship training in Addictions at University of Cleveland Hospitals and Case Western Reserve University in 1999. He received Board Certification from the American Board of Addiction Medicine in 2010 and became a certificant of the Canadian Society of Addiction Medicine in 2012. Dr. Sobey is a Clinical Instructor at the University of British Columbia Faculty of Medicine, Department of Family Practice.

Dr. Sobey has been a CSAM member since 2008, the British Columbia representative to CSAM since 2010, President-Elect from 2013 – 2015, and is the current CSAM President.Dr. Sobey. His practice has been limited to addiction medicine since 1999. He is currently the lead physician and an addiction medicine consultant for the Royal Columbian Hospital Addiction Medicine Service in New Westminster, BC.  He also acts as an Occupational Addiction Medicine consultant to both public and private organizations. He has an active methadone practice in New Westminster and also works in abstinence-based care.

Dr. Sobey was the Regional Divisional Lead for Addictions in Fraser Health Authority from April 2011 to May 2013.  He was on the Member Advisory Committee on Opiate Dependence – College of Physicians and Surgeons of British Columbia (CPSBC) from 2002 to 2013 and was Chair of the committee from 2011 until 2013.

Dr. Sobey is currently sitting on the following CSAM committee(s): Executive, Conference, and Membership and is honoured by the opportunity to act as this year’s Conference Co-Chair.

2019 Conflict of Interest

Laura Evans MD, CCFP, CSAM (Certificant), ISAM (Certification), ABAM (Diplomate)
Secretary/Treasurer - 1st Term: 2016-2020

Laura Evans MD, CCFP, CSAM (Certificant), ISAM (Certification), ABAM (Diplomate)

 

Laura Evans MD CCFP CSAM (Certificant), ISAM (Certification, ABAM (Diplomate)

Dr. Evans received her MD Degree from McMaster and completed her residency at the St. Paul’s Family Medicine Residency Program, the University of British Columbia in 2007.  Her residency focused on marginalized populations in Vancouver and provided her initial training in the medication-assisted treatment of opioid use disorders.

Following residency, and after briefly working in Kamloops BC, Dr. Evans returned to her ‘hometown’ of Winnipeg for four years, where she worked at an inner-city clinic.  There, she instigated a primary care based methadone program within the Winnipeg Regional Health Authority.

In 2012, Dr. Evans moved to Calgary Alberta where she transitioned to full-time work across the breadth of Addiction Medicine.  Currently, Dr. Evans works at the Alberta Health Services Opioid Dependence Program, at Renfrew Recovery and Detoxification Centre, and provides inpatient addiction consultations at Calgary’s Foothills Hospital.  Dr. Evans is passionate regarding her work primarily with adolescents at the outpatient Foothills Concurrent Program.  She also works at the Calgary Urban Project Society or ‘CUPS’ Medical Centre providing inner-city primary care integrated with opioid substitution.

Dr. Evans currently sits on the ISAM Exam Editorial Committee, and also teaches residents and medical students across settings, as a Clinical Assistant Professor in the Department of Family Medicine at the University of Calgary.

Dr. Evans has been a member of CSAM since 2013 and is currently on the CSAM Conference and Membership (Chair) committees.

Dr. Evans has been a CSAM Board Representative for Alberta and the North West Territories from 2013 to present.

2019 Conflict of Interest

Naved Ali MD, CCFP, CSAM (Certificant), ABAM (Diplomate)
British Columbia and Yukon Regional Director - 1st Term: 2018-2019

Naved Ali MD, CCFP, CSAM (Certificant), ABAM (Diplomate)

Naved Ali MD, CCFP, CSAM (Certificant), ABAM (Diplomate)

Dr. Naved Ali MD was born in Edmonton, Alberta and received his MD from the University of Alberta in 1987. After obtaining his CCFP in 1989, he worked in full-service family practice, until eventually focusing on the area of Substance Use and Mental Health. He was certified in Addiction Medicine by ASAM in 1998 and received  CSAM certification in 2007 and ABAM Dip status 1n 2009.

Dr. Ali is currently Medical Manager of Stepping Stones in North Vancouver, an outpatient clinic providing services ranging from harm reduction to an intensive abstinence-focused Day Program. He supervises and delivers Day Program groups, and provides both outpatient and inpatient consultations including prescribing Opiate Agonists and other Medication Assisted Treatments.  He also has experience working at residential treatment and inpatient detox centres.

Dr. Ali also assesses and treats individuals working in safety-sensitive occupations.  He has monitored commercial airline pilots in recovery for the Airline Pilots Association since 2009 and previously worked at the British Columbia Physician Health Program from 2008-2012. He is particularly interested in outcome measurements, as well as workplace policy regarding substance use, misuse and addiction.

In addition to his clinical work, Dr Ali is well respected as an educator.  He was the Director of Addiction Medicine at the University of British Columbia from 1996-1998, where he taught the Faculty of Medicine Addiction Medicine curriculum.  He continues to supervise students, residents and practising physicians.  Dr. Ali is also a sought after speaker, having given over 100 presentations internationally to medical conferences, health care providers, patients and their families, public agencies and private corporations.  Most recently, he has been an invited speaker to the annual ALPA Pilots Assistance Forum in Washington, DC where he spoke on the relationship between Trauma and Addiction.  Dr. Ali currently lives in Vancouver, British Columbia with his two daughters.

Dr. Ali is in his first term as a CSAM board representative for British Columbia and the Yukon.

2019 Conflict of Interest

Robert Tanguay BSc, MD, FRCPC, CSAM (Certificant), ISAM (Certificant)
Alberta & North West Territories Regional Director - 1st Term: 2017-2021

Robert Tanguay BSc, MD, FRCPC, CSAM (Certificant), ISAM (Certificant)

 

Dr. Tanguay is a Psychiatrist who completed 2 fellowships, one in Addiction Medicine and one in Pain Medicine. He is a clinical assistant professor with the departments of Psychiatry and Surgery at the Cumming School of Medicine, University of Calgary. He is the Medical Lead for Alberta Opioid Dependency training program and Alberta Addiction Education Sessions for Alberta Health Services. Dr. Tanguay is the Regional Director for Alberta and North West Territories for the Canadian Society of Addiction Medicine (CSAM) and the incoming President of the Pain Society of Alberta.  He is the founder of the Opioid Deprescribing Program with Alberta Health Services and the Transitional Outpatient Pain Program for Spine (TOPPS) clinic working with spinal surgeons to optimize spinal surgery outcomes. Dr. Tanguay is the incoming co-chair of the AHS Alberta Pain Strategy. Dr. Tanguay is also the lead lecturer for Addiction for the Cumming School of Medicine, University of Calgary. Academically he is involved in research in addiction, chronic pain, opioids, and cannabis and is a member of the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research & Education at the University of Calgary.

Dr. Tanguay has been a member of CSAM since 2015 and is the Alberta & North West Territories Regional Director on the board of CSAM.

2019 Conflict of Interest

Wiplove Lamba MD, FRCPC, ISAM (Certificant) ABAM (Diplomate)
Ontario Regional Director - 1st Term: 2017-2021

Wiplove Lamba MD, FRCPC, ISAM (Certificant) ABAM (Diplomate)

Wip Lamba MD, FRCPC, ISAM (Certificant) ABAM (Diplomate)

Dr. Lamba completed his medical school at the University of Ottawa in 2006, his Psychiatry residency at the University of Toronto in 2011, and an addiction fellowship at the Centre for Addiction and Mental Health in 2012.

He is currently the education lead for the addiction program at St. Michael’s Hospital in Toronto where over 50 residents rotate through their service per year. This service involves a multidisciplinary inpatient consultation team including internal medicine, family medicine, emergency medicine, and psychiatry. It also includes a nurse practitioner, peer support and a case manager. They also offer transitional follow-up and psychosocial groups based on motivational interviewing and the community reinforcement approach.

Dr. Lamba’s academic focus is in capacity building in the generalist. He is a member of the education committee at CSAM since 2016, and with Dr. Yelena Chorny led the first buprenorphine course at the CSAM conference in 2017 that was data-sponsored by the American Academy of Addiction Medicine.

Dr. Lamba has been a CSAM Board Representative for Ontario from 2017 to present.

2019 Conflict of Interest

Vacant
Quebec Regional Director - 1st Term: 2015-2019

 

 

Simon Dubreucq MD, FRCPC, MSc
Quebec Regional Director - 1st Term: 2017-2021

Simon Dubreucq MD, FRCPC, MSc

Simon Dubreucq  MD, FRCFP, MSc

Dr. Dubreucq obtained his medical degree from the University of Montreal in 2008.   He completed a psychiatry residency at the University of Montreal in 2013, and a one-year Fellowship at Université Laval in 2014

Dr. Dubreucq is an Assistant Professor of Psychiatry at University of Montreal and works as a psychiatrist in a specialized concurrent disorder clinic at Centre Hospitalier Université de Montréal (CHUM).

He participates in different research projects at the CRCHUM (Centre de Recherche du CHUM) and is involved in the teaching and supervision of pre-graduate medical students, family medicine residents and psychiatry residents.

Dr. Dubreucq has been a member of CSAM since 2016 and has been a Quebec Regional Director on the CSAM board since 2017.

2019 Conflict of Interest

Dave Martell BSc MD CCFP (AM) FCFP CSAM (Certificant) ISAM (Certification)
Member At Large - 1st Term: 2015-2019

Dave Martell BSc MD CCFP (AM) FCFP CSAM (Certificant) ISAM (Certification)

Dave Martell BSc MD CCFP FCFP CISAM CCSAM

Dr. Martell completed undergraduate study at Mount Allison University in 1993, a medical degree at the University of Western Ontario in 1997, and Family Medicine Residency at Dalhousie University in 1999. In 2019, after almost 19 years in General Family Medicine, he transitioned to a career in Addiction Medicine. He lives and works on the South Shore of Nova Scotia.

Dr. Martell is a Peer Reviewer and serves on the Peer Review Committee of the College of Physicians and Surgeons of Nova Scotia. He has served on the Practice Review Committee of the Nova Scotia Prescription Monitoring Program and course faculty for the Safe Opioid Prescribing Course offered by the Atlantic Mentorship Network for Pain and Addiction. He is a front line Addiction Medicine provider with the South Shore Opioid Outreach Treatment Team, Direction 180, and Wagmatcook First Nation, all front-line collaborative multi-disciplinary teams. In 2019, he began work on the Opioid Use Disorder Practice Support Program, a novel knowledge translation and mentoring support service for primary care collaboratives in Nova Scotia.

Dr. Martell has been a Board Representative for the Maritime Provinces from 2015 to present.

2019 Conflict of Interest

Wael Shublaq M.B.B.CH, PhD, Dip. OB/GYN,
Newfoundland Regional Director -2nd Term: 2016-2020

Wael Shublaq M.B.B.CH, PhD, Dip. OB/GYN,

Wael Shublaq  M.B.B.CH, PhD, Dip. OB/GYN,

Dr. Shublaq completed his M.B.B.CH training in Alexandria, Egypt in November 1983. His Diploma of Speciality (1994) and his PhD (1995) both in OB/GYN were completed in Wroclaw, Poland.

In 2002, Dr. Wael moved to Newfoundland, Canada and completed his Clinical Associate Neurosurgery by 2009.  He entered a Residency Training Program – Psychiatry – MUN from 2009 – 2011 which is not completed.

Dr. Shublaq was a GP in the Mental Health and Addictions Program, Psychiatry Department in Newfoundland from 2011 – 2015.  He is currently a Family GP with a solo practice clinic, and a methadone prescriber in the ODT Centre, in St. John’s, NL.

He has been a peer reviewer for the Journal of Addiction Medicine.

Dr. Shublaq has been a member of CSAM since 2011 and has represented the board as the Newfoundland Regional Director since 2012.

2019 Conflict of Interest

Nady el-Guebaly MD, FRCPC, DPH, DPsych, DFASAM, DFAAAP, EFACP, DFCPA, CSAM (Certificant), ISAM (Certification), ABAM (Diplomate)
Canadian Journal of Addiction Editor-in-Chief/Board Member at Large - 2nd Term: 2013-2017

Nady el-Guebaly MD, FRCPC, DPH, DPsych, DFASAM, DFAAAP, EFACP, DFCPA, CSAM (Certificant), ISAM (Certification), ABAM (Diplomate)

Nady el-Guebaly MD, FRCPC, DPH, DPsych, DFASAM, DFAAAP, EFACP, DFCPA, CSAM (Certificant), ABAM (Diplomate), ISAM (Certification)

Dr. el-Guebaly’s introduction to mental health and addiction medicine dates back to 1969 during initial psychiatric training in the United Kingdom, followed by training in Canada and the United States

Addiction related work includes being the current Professor and Head of Division of Addiction, Department of Psychiatry at the University of Calgary, and the founding past Medical Director of the Calgary Health Region Addiction Centre and Program. Dr. el-Guebaly was the Founding Past President of the International Society of Addiction Medicine, its Executive Medical Director for another 6 years, and currently Chief Examiner of the International Certification Examination and Senior Editor of the recent Textbook of Addiction Treatment: International Perspectives (Springer 2015).

Dr. el-Guebaly completed three 3-year terms as Board Chair of the Alberta Gaming Research Institute and is now the Alberta Gambling Research Institute’s current Research Director as well as Editor in Chief of the Canadian Journal of Addiction for the last 4 years. These interests have resulted in 260 peer-reviewed papers, 80 chapters, 568 presentations, and 60 past and current grants totaling $7 million.

He is a member, of Alberta’s Responsible Gambling Advisory Committee, the Royal College Addiction Medicine Specialty Committee, the Provincial Addiction Curricula and Experiential Skills Training for Alberta Health Services, and the CSAM Conference committee.

Dr. el-Guebaly has been a CSAM member since 1995 and was a past President from 1995 – 1997. He is currently the Canadian Journal of Addiction Editor in Chief and a CSAM Board Member at Large.

2019 Conflict of Interest

 

Ronald Fraser MD, CSPQ, FRCPC
Board Member at Large - 1st Term: 2015-2019

Ronald Fraser MD, CSPQ, FRCPC

Ron Fraser MD, CSPQ, FRCPC

Dr. Fraser received his medical degree from Dalhousie University in Halifax, Nova Scotia in 1995 and completed his psychiatry residency at McGill University in Montreal, Quebec in 2000. He completed a fellowship in addiction psychiatry at McGill in 2001. Dr. Fraser is currently an Associate Professor of Psychiatry at McGill and an Assistant Professor of Psychiatry at Dalhousie.

Dr. Fraser is the head of the inpatient detoxification service and an attending staff physician on the addiction unit of the department of psychiatry at the McGill University Health Center (MUHC). He is also the director of the Long Term Treatment Program for Borderline Personality Disorder in the Department of Psychiatry at the MUHC. Additionally, he is a consulting psychiatrist for addiction services in the Nova Scotia Health Authority and the Co-Founder and Clinical Director of 360dtx treatment facility in Montreal Quebec.

Dr. Fraser has a special research interest in the interface between addiction and personality disorders.

Dr. Fraser has been a member of CSAM since 2014. He is on the education committee and has been a regional board director for Quebec since 2015.

2019 Conflict of Interest

Claudette Chase MD, FCFP
Board Member at Large - 1st Term: 2015-2019

Claudette Chase MD, FCFP

Claudette Chase MD, FCFP

Dr. Chase completed her training at McMaster University in 1992. She completed a residency in Rural Family medicine through the University of British Columbia in 1994. She obtained her Fellowship from the College of Family Physicians of Canada Fellowship in 2003 and has received a Fellowship of Rural and Remote Medicine from the Society of Rural Physicians of Canada

She has held many leadership roles, including being the president of the Ontario College of Family Physicians from 2002 to 2003. Dr. Chase is currently affiliated with the Northern Ontario School of Medicine and in the past has been the family medicine director McMaster University from 2005-2006.

Dr. Chase helped pioneer and still manages a community-based addiction treatment program in a remote First Nation. She is also involved with a treatment team that serves the First Nation high school in Thunder Bay, and two other First Nations.

She serves on the Ontario Ministry of Health Committee, Methadone Treatment and Services Advisory Committee, and the Adult Chronic Pain Advisory Board.  She has presented on addiction treatment at Family Medicine Forum for the past three years, and at the CPSO in 2013 and 2014.

Dr. Chase has been a member of CSAM since 2013 and is currently on the CSAM Membership committee. She has been on the CSAM board as a Member at Large since 2015.

2019 Conflict of Interest

George Budd Pharm.D.,B.Sc.(Pharm.), R.PEBC, R.Ph.
Associate Member - 1st Term: 2015-2019

George Budd Pharm.D.,B.Sc.(Pharm.), R.PEBC, R.Ph.

George Budd Pharm.D.,B.Sc.(Pharm.), R.PEBC, R.Ph.

George P. Budd, a practicing pharmacist since 1992, obtained his Doctor of Pharmacy degree in 2011 from Idaho State University. He has experience in many different practice settings within the profession such as hospital pharmacy residency, community pharmacy and pharmacy manager.  Former Senior Investigator for the College of Pharmacists of BC (CPBC), and currently a Professional Conduct Review Consultant/Policy Liaison with the College of Registered Nurses of BC (CRNBC).

Dr. Budd is currently on the Board of Directors of the Canadian Society of Addiction Medicine (CSAM) and is currently a public representative to the Methadone Panel at the College of Physicians and Surgeons of BC.

Additionally, he has been a representative on national and provincial advisory committees such as CCSA National Dialogue on Prescription Drug Misuse, Opioid Substitution Treatment Psychosocial Service Framework and many others.

Dr. Budd is dedicated to establishing best practices in the area of addiction medicine and has worked closely with addiction physicians and other disciplines with a strong belief that collaboration is key to achieving desired health outcomes.

2019 Conflict of Interest

 

S. Monty Ghosh MD, MBT, MSc., DM-EMDM, FRCPC, ISAM(Certification)
IT Liaison - Term: 2018-2020

S. Monty Ghosh MD, MBT, MSc., DM-EMDM, FRCPC, ISAM(Certification)

Dr. Ghosh completed his medical school at the University of Calgary and Internal Medicine training at the University of Alberta.  He splits his time between Edmonton at The University of Alberta Hospital and Calgary where he works with Calgary’s most vulnerable populations at The Alex and The Opioid Dependency Program.   He has a particular passion for working with individuals who live with homelessness, a history of corrections, immigrants, and First Nations populations.

He also has a passion for addiction research and education and enjoys travelling on his free time.

Dr. Ghosh has been a CSAM board representative as IT Liaison since 2018.

2019 Conflict of Interest